The lack of a second aPL evaluation is another drawback of this study, but the systematic evaluation of IgA B2GPI in patients with APS has demonstrated that IgA aB2GPI positivity is extremely stable and persists for years. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.